Radioligands for tropomyosin receptor kinase (TRK) positron emission tomography

被引：0
|
作者：
Thiel, A. [1 ,2 ]
Bernard-Gauthier, V. [3 ]
Bailey, J. J. [3 ]
Kaiser, L. [4 ]
Bartenstein, P. [4 ]
Scott, P. [5 ]
Schirrmacher, R. [3 ]
机构：
[1] McGill Univ, McConnell Brain Imaging Ctr, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada
[2] Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ HT3 1E2, Canada
[3] Univ Alberta, Div Oncol Imaging, Dept Oncol, Edmonton, AB T6G 2R3, Canada
[4] Ludwig Maximilians Univ Munchen, Dept Nucl Med, Marchioninistr 15, D-81377 Munich, Germany
[5] Univ Michigan, Dept Radiol, Med Sch, Div Nucl Med, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP01-M08
引用
收藏
页码：529 / 530
页数：2
相关论文
共 50 条
  • [31] SOMATIC REARRANGEMENT OF THE TROPOMYOSIN-RECEPTOR-KINASE (TRK) ONCOGENE IS RARE IN GASTROINTESTINAL CANCER
    FEY, MF
    THEIN, SL
    BRITISH JOURNAL OF CANCER, 1988, 57 (04) : 403 - 404
  • [32] Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer
    Drilon, A.
    Moreno, V.
    Patel, J.
    Lassen, U. N.
    Solomon, B.
    Rosen, L.
    Leyvraz, S.
    Tan, D. S. W.
    Reeves, J. A.
    Dima, L.
    Brega, N.
    Kummar, S.
    Farago, A. F.
    ANNALS OF ONCOLOGY, 2020, 31 : S834 - S834
  • [33] Efficacy and Safety of Larotrectinib in Patients with Tropomyosin Receptor Kinase (TRK) Fusion Lung Cancer
    Tan, D.
    Farago, A.
    Kummar, S.
    Moreno, V.
    Patel, J.
    Lassen, U.
    Solomon, B.
    Rosen, L.
    Leyvraz, S.
    Reeves, J.
    Brega, N.
    Dima, L.
    Childs, B.
    Drilon, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S176 - S176
  • [34] Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase (TRK) fusion cancer
    Brose, M. S.
    Shen, L.
    Tan, D. S. W.
    Kummar, S.
    Lin, J. J.
    McDermott, R.
    Berlin, J.
    Tahara, M.
    Lassen, U. N.
    Leyvraz, S.
    Patel, J. D.
    Norenberg, R.
    Dima, L.
    Brega, N.
    Hong, D. S.
    Drilon, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S600 - S601
  • [35] Efficacy and Safety of Larotrectinib in Patients with Tropomyosin Receptor Kinase (TRK) Fusion Lung Cancer
    Drilon, A.
    Moreno, V.
    Patel, J.
    Lassen, U.
    Solomon, B.
    Rosen, L.
    Leyvraz, S.
    Tan, D. S. W.
    Reeves, J. A.
    Dima, L.
    Brega, N.
    Kummar, S.
    Farago, A. F.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S30 - S31
  • [36] Towards decreased Protodeboronation in the Late-Stage CopperMediated Radiofluorination of the Positron Emission Tomography Tracer for Tropomyosin Receptor Kinase [18F]TRACK
    Jaworski, Carolin
    Delaney, Connor
    Kassel, Vincent
    Denmark, Scott
    Schirrmacher, Ralf
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S81 - S81
  • [37] ON-TRK: A NON-INTERVENTIONAL STUDY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION SOLID TUMORS
    Tabatabai, Ghazaleh
    Trent, Jonathan
    Novello, Silvia
    Passiglia, Francesco
    Burcoveanu, Domnita-Ileana
    Norenberg, Ricarda
    Laetsch, Theodore
    NEURO-ONCOLOGY, 2023, 25
  • [38] DEVELOPMENT OF NOVEL RADIOLIGANDS TO IMAGE SIGMA RECEPTORS IN THE BRAIN USING POSITRON EMISSION TOMOGRAPHY
    CAMPBELL, BG
    WEBER, E
    CLINICAL RESEARCH, 1991, 39 (01): : A85 - A85
  • [39] Syntheses of the first endothelin-A- and -B-selective radioligands for positron emission tomography
    Johnström, P
    Aigbirhio, FI
    Clark, JC
    Downey, SPMJ
    Pickard, JD
    Davenport, AP
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 : S58 - S60
  • [40] POSITRON EMISSION TOMOGRAPHY - EXAMINATION OF CHEMICAL TRANSMISSION IN THE LIVING HUMAN BRAIN - DEVELOPMENT OF RADIOLIGANDS
    FARDE, L
    HALL, H
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1992, 42-1 (2A): : 260 - 264
12345